In the high-stakes world of biotechnology, where speed to market is often king, one company is embracing the unconventional strategy of letting its primary rival cross the finish line first. This calculated patience is the cornerstone of Alkermes's ambitious plan to not only capture a
The remarkable progress in treating multiple myeloma has created a formidable, and somewhat ironic, challenge for the very innovation needed to build upon that success. As current therapies drive patients into longer and deeper remissions, the traditional benchmarks for proving a new drug’s worth h
With a deep background in medical technology and a keen eye on the oncology space, Faisal Zain has tracked the evolution of immunotherapies from promising concepts to clinical realities. Today, we delve into the high-stakes world of T cell engagers, exploring Bristol Myers Squibb's renewed bet
Introduction The fight against cancer often extends far beyond the operating room, where the lingering threat of recurrence casts a long shadow over patients who have undergone successful tumor removal. This challenge has catalyzed a new wave of innovation focused not just on treatment but on
The precision of modern medical imaging promises a clear path to diagnosis and treatment, yet for patients with soft tissue sarcomas, this promise is frequently broken by inconsistent and incomplete data gathered at the most critical early stages. While magnetic resonance imaging stands as the
The subtle interplay of light, space, and nature within a hospital's walls has a more profound impact on patient recovery and staff morale than decades of conventional medical facility planning have ever acknowledged. The quality of healthcare is traditionally measured by the skill of its
